Gujarat Terce Laboratories Limited reported earnings results for the second quarter and six months ended September 30, 2021. For the second quarter, the company reported sales was INR 101.26 million compared to INR 71.98 million a year ago. Revenue was INR 102.02 million compared to INR 72.85 million a year ago. Net income was INR 4.54 million compared to net loss of INR 0.156 million a year ago. Basic earnings per share from continuing operations was INR 0.61. Diluted earnings per share from continuing operations was INR 0.61. For the six months, sales was INR 200.63 million compared to INR 121.78 million a year ago. Revenue was INR 202.07 million compared to INR 123.33 million a year ago. Net income was INR 20.54 million compared to net loss of INR 4.59 million a year ago. Basic earnings per share from continuing operations was INR 2.77. Diluted earnings per share from continuing operations was INR 2.77.